Parya Saberi, PharmD, MAS

Title(s)Professor, Medicine
SchoolSchool of Medicine
Phone415-502-1000 ext. 17171
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Massachusetts College of Pharmacy, Boston, MAPharmD06/2004
    Montefiore Medical Center , Bronx, NY06/2005Clinical Pharmacy Residency
    University of California, San Francisco, San Francisco, CA06/2006 HIV Specialty Pharmacy Residency
    University of California, San Francisco, San Francisco, CAMAS06/2011Master's in Clinical Research
    University of California, San Francisco, San Francisco, CAFellowship06/2012
    Saint Mary’s College of California, Moraga, CAMFA06/2021Master’s in Fine Arts
    California Institute for Integral Studies, San Francisco, CA06/2024Psychedelic-Assisted Therapies and Research Certificate Program

    Collapse Overview 
    Collapse overview
    Parya Saberi, PharmD, MAS, MFA, AAHIVP is a Professor at the Division of Prevention Science in the Department of Medicine at the University of California, San Francisco (UCSF) and the Director of the UCSF Center for AIDS Prevention Studies Development and Mentoring Core. Dr. Saberi is funded by the National Institutes of Health and the Centers for Disease Control and Prevention. Her research aims to improve healthcare by removing barriers related to finances, transportation, work schedule, childcare, ability, and stigma, by offering interventions to individuals outside of a traditional clinical setting (e.g., homes or pharmacies). She has received numerous grants to develop interventions, including technology-based solutions to improve HIV treatment and prevention care continuums. Additionally, she is involved in several projects focused on increasing pre-exposure prophylaxis uptake from pharmacies, including the provision of long-acting injectables at pharmacies. Finally, Dr. Saberi is an expert clinical consultant for the CDC/HRSA-funded National Clinician Consultation Center (HIV Warmline, PEPline, and PrEPline), which has the mission of promoting health equity in the US by supporting healthcare professionals through evidence-informed, person-centered clinical consultation and education.

    Collapse Research 
    Collapse research activities and funding
    RFA-PS-23-004, Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home (INVITE-Home)
    NIH U01PS005259Sep 30, 2023 - Sep 29, 2027
    Role: Principal Investigator
    Comprehensive, tailored, technology-based intervention to improve virologic suppression among youth and young adults living with HIV
    NIH R01MH131415Sep 1, 2022 - Jun 30, 2027
    Role: Principal Investigator
    Perceptions of Risks and Benefits of Participating in HIV Cure-related Research among Diverse Youth and Young Adults Living with HIV in the United States
    NIH R21MH122280Apr 1, 2020 - Mar 31, 2022
    Role: Principal Investigator
    Improving the HIV PrEP Cascade using an Intervention for Healthcare Providers
    NIH R01NR017573Sep 20, 2017 - Jun 30, 2022
    Role: Principal Investigator
    A Mobile Health Application for Engagement in Care among Youth Living with HIV
    NIH R34MH114604Aug 15, 2017 - Jun 30, 2021
    Role: Principal Investigator
    Rx Pix: A Novel Way to Assess Antiretroviral Adherence with Pharmacy Refill Dates
    NIH R21MH108414Feb 19, 2016 - Dec 31, 2018
    Role: Principal Investigator
    Technology-based adaptive treatment strategies for antiretroviral adherence
    NIH K23MH097649Jun 15, 2012 - Apr 30, 2018
    Role: Principal Investigator
    Quality of Sleep in HIV-Infection: associations with treatment and adherence
    NIH F32MH086323Jul 1, 2009 - Jun 30, 2012
    Role: Principal Investigator

    Collapse Featured Content 
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Economic factors associated with county-level mental health - United States, 2019. PLoS One. 2025; 20(6):e0300939. Bolduc MLF, Saberi P, Neilands TB, Mercado CI, Johnson SB, Freggens ZRF, Banks D, Njai R, Bullard KM. PMID: 40465555.
      View in: PubMed   Mentions:
    2. Qualitative Results from a Pilot Study of an Automated Directly Observed Therapy Intervention Using Artificial Intelligence with Conditional Economic Incentives among Young Adults with HIV. AIDS Behav. 2025 May 10. Wagner LD, Mancuso N, Stoner MCD, Smith L, Ming K, Patani H, Sukhija-Cohen AC, Granados Y, Napierala S, Saberi P. PMID: 40347396.
      View in: PubMed   Mentions:    Fields:    
    3. Lessons Learned in Engaging Adolescents and Young Adults to End the US HIV Epidemic. J Acquir Immune Defic Syndr. 2025 Apr 15; 98(5S):e88-e97. Macapagal K, Stoner MCD, Guss CE, Sukhija-Cohen AC, Moucheraud C, Saberi P, Maragh-Bass AC. PMID: 40163059.
      View in: PubMed   Mentions:    Fields:    
    4. Cost-effectiveness of HIV pre-exposure prophylaxis among female sex workers in Iran. Sci Rep. 2025 Mar 05; 15(1):7747. Moameri H, Goudarzi R, Haghdoost AA, Gouya MM, Saberi P, Mirzazadeh A, Shahrbabaki PM, Sharifi H. PMID: 40044976; PMCID: PMC11882906.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    5. Insights on HIV Care Engagement Strategies from Seven Interventions Serving Key Populations in the United States: A Qualitative Study. AIDS Patient Care STDS. 2025 Mar; 39(3):102-115. Moran L, Bolton AT, Maiorana A, Guzé MA, Bourdeau B, Shade SB, Rebchook GM, Saberi P, Palomares M, Hinchcliffe G, Keuroghlian AS, Psihopaidas D, Myers JJ, Koester KA. PMID: 39964750.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Telehealth Interventions to Improve HIV Care Continuum Outcomes: A Narrative Review. AIDS Patient Care STDS. 2025 Apr; 39(4):129-140. Krebs D, Goldhammer H, Dorfman M, Moore MP, Chavis NS, Psihopaidas D, Downes A, Bourdeau B, Saberi P, Grasso C, Mayer KH, Keuroghlian AS. PMID: 39929177.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Facilitators and barriers of HIV pre-exposure prophylaxis use among four key populations in Iran. BMC Health Serv Res. 2024 Nov 19; 24(1):1433. Moameri H, Shahrbabaki PM, Tavakoli F, Saberi P, Mirzazadeh A, Goudarzi R, Sharifi H. PMID: 39563358; PMCID: PMC11575091.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    8. Assessing pharmacy students' HIV pre-exposure prophylaxis (PrEP) prescribing knowledge, PrEP attitudes, and HIV-related stigma. J Am Coll Clin Pharm. 2024 Nov; 7(11):1107-1113. Bustria CN, Yohannes F, Cocohoba J, Nguyen L, Patel N, Saberi P. PMID: 40297170; PMCID: PMC12036671.
      View in: PubMed   Mentions:
    9. Clinician Specialty and HIV PrEP Prescription Reversals and Abandonments. JAMA Intern Med. 2024 Oct 01; 184(10):1204-1211. Bakre S, Chang HY, Doshi JA, Goedel WC, Saberi P, Chan PA, Nunn A, Dean LT. PMID: 39158923; PMCID: PMC11334010.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    10. Results From a Pilot Study of an Automated Directly Observed Therapy Intervention Using Artificial Intelligence With Conditional Economic Incentives Among Young Adults With HIV. J Acquir Immune Defic Syndr. 2024 06 01; 96(2):136-146. Stoner MCD, Smith L, Ming K, Mancuso N, Patani H, Sukhija-Cohen A, Granados Y, Wagner D, Johnson MO, Napierala S, Neilands TB, Saberi P. PMID: 38363868; PMCID: PMC11108745.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    11. HIV pre-exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2024 Mar 6. Saberi SP, Su SH, Mendiola MJ, Gruta GC, Lutes LE, Dong DB, Bositis BC, Chu CC. .
      View in: Publisher Site   Mentions:
    12. HIV pre-exposure prophylaxis champion preceptorship training for pharmacists and nurses in the United States. J Am Coll Clin Pharm. 2024 May; 7(5):458-470. Saberi P, Su H, Mendiola J, Gruta C, Lutes ER, Dong B, Bositis C, Chu C. PMID: 40125524; PMCID: PMC11928167.
      View in: PubMed   Mentions:
    13. Estimating The Impact Of Out-Of-Pocket Cost Changes On Abandonment Of HIV Pre-Exposure Prophylaxis. Health Aff (Millwood). 2024 01; 43(1):36-45. Dean LT, Nunn AS, Chang HY, Bakre S, Goedel WC, Dawit R, Saberi P, Chan PA, Doshi JA. PMID: 38190604; PMCID: PMC10996384.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    14. Youth Ending the HIV Epidemic (YEHE): Protocol for a pilot of an automated directly observed therapy intervention with conditional economic incentives among young adults with HIV. PLoS One. 2023; 18(12):e0289919. Stoner MCD, Ming K, Wagner D, Smith L, Patani H, Sukhija-Cohen A, Johnson MO, Napierala S, Neilands TB, Saberi P. PMID: 38134037; PMCID: PMC10745168.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    15. iVY: protocol for a randomised clinical trial to test the effect of a technology-based intervention to improve virological suppression among young adults with HIV in the USA. BMJ Open. 2023 10 06; 13(10):e077676. Saberi P, Stoner MCD, McCuistian CL, Balaban C, Ming K, Wagner D, Chakraborty B, Smith L, Sukhija-Cohen A, Neilands TB, Gruber VA, Johnson MO. PMID: 37802624; PMCID: PMC10565330.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    16. Acceptability of the LetSync App Wireframes for an mHealth Intervention to Improve HIV Care Engagement and Treatment Among Black Partnered Sexual Minority Men: Findings from In-Depth Qualitative Interviews. JMIR Form Res. 2023 Aug 25; 7:e43676. Becker N, Kim HC, Bright DJ, Williams Iii R, Anguera JA, Arnold EA, Saberi P, Neilands TB, Pollack LM, Tan JY. PMID: 37624634; PMCID: PMC10492169.
      View in: PubMed   Mentions:
    17. Medical mistrust of health systems as a moderator of resilience and self-reported HIV care engagement in Black and Latinx young adults living with HIV. Cultur Divers Ethnic Minor Psychol. 2025 Jan; 31(1):118-123. Sauceda JA, Campbell CK, Ndukwe SO, Dubé K, Saberi P. PMID: 37589681; PMCID: PMC10873476.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Brief Report: The Influence of the COVID-19 Pandemic on the Physical, Social, and Mental Health of Black and Latinx Young People With HIV in the United States. J Acquir Immune Defic Syndr. 2023 07 01; 93(3):187-190. Sauceda JA, Dubé K, Harris O, Campbell CK, Ndukwe S, Saberi P. PMID: 36913727; PMCID: PMC10272066.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
    19. Correction: Young Adult Perspectives on Sex, Dating, and PrEP Use During the Pandemic and Improving the Future of PrEP Care. AIDS Behav. 2023 Jul; 27(7):2439. Camp CE, Chan CT, Saberi P. PMID: 36929322; PMCID: PMC11837142.
      View in: PubMed   Mentions:    Fields:    
    20. Cash Transfer Apps are a Feasible, Acceptable, and More Equitable Method for Compensating Participants in HIV Research. J Acquir Immune Defic Syndr. 2023 07 01; 93(3):e9-e11. Campbell CK, Dubé K, Sauceda JA, Sevelius JM, Green-Ajufo B, Brown B, Ndukwe S, Saberi P. PMID: 36976553; PMCID: PMC10272053.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    21. Extreme weather events and HIV: development of a conceptual framework through qualitative interviews with people with HIV impacted by the California wildfires and their clinicians. BMC Public Health. 2023 05 25; 23(1):950. Saberi P, Ming K, Arnold EA, Leddy AM, Weiser SD. PMID: 37231393; PMCID: PMC10209556.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. New preexposure prophylaxis options need updated counseling approaches: reframing 'risk' in HIV prevention counseling for young sexual and gender minorities of color. AIDS. 2023 07 15; 37(9):1361-1366. Maragh-Bass AC, Stoner MCD, Castellanos-Usigli A, Agarwal H, Katz AWK, Patani H, Sukhija-Cohen A, Campbell L, Arreola S, Saberi P. PMID: 37070546; PMCID: PMC11499167.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    23. Preferences for HIV Treatment Formulations Among Young Adults With HIV in the United States. J Acquir Immune Defic Syndr. 2023 02 01; 92(2):e7-e10. Saberi P, Stoner MCD, Eskaf S, Ndukwe S, Campbell CK, Sauceda JA, Dubé K. PMID: 36343377; PMCID: PMC9839471.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Young Adult Perspectives on Sex, Dating, and PrEP Use During the Pandemic and Improving the Future of PrEP Care. AIDS Behav. 2023 Jul; 27(7):2430-2438. Camp CE, Chan CT, Saberi P. PMID: 36629971; PMCID: PMC9832408.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    25. Pharmacy Deserts and Pharmacies' Roles Post-Extreme Weather and Climate Events in the United States: A Scoping Review. J Prim Care Community Health. 2023 Jan-Dec; 14:21501319231186497. Sahota H, Guzman S, Tordera L, Chan M, Cocohoba J, Saberi P. PMID: 37431885; PMCID: PMC10338653.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. Willingness of Racially Diverse Young Adults Living with HIV to Participate in HIV Cure Research: A Cross-Sectional Survey in the United States. AIDS Res Hum Retroviruses. 2023 08; 39(8):381-399. Dubé K, Campbell CK, Eskaf S, Sauceda JA, Ndukwe S, Henley L, Persaud D, Deeks SG, Auerbach JD, Saberi P. PMID: 36226414; PMCID: PMC10387162.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    27. Overcoming Challenges of Online Research: Measures to Ensure Enrollment of Eligible Participants. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):232-236. Campbell CK, Ndukwe S, Dubé K, Sauceda JA, Saberi P. PMID: 36094490; PMCID: PMC9731236.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Drought, HIV Testing, and HIV Transmission Risk Behaviors: A Population-Based Study in 10 High HIV Prevalence Countries in Sub-Saharan Africa. AIDS Behav. 2023 Mar; 27(3):855-863. Epstein A, Nagata JM, Ganson KT, Nash D, Saberi P, Tsai AC, Charlebois ED, Weiser SD. PMID: 36066761; PMCID: PMC11909628.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    29. Exploration of a Mobile Technology Vulnerability Scale's association with antiretroviral adherence among young adults living with HIV in the United States. Mhealth. 2022; 8:23. Saberi P, Eskaf S, Campbell CK, Neilands TB, Sauceda JA, Dubé K. PMID: 35928514; PMCID: PMC9343971.
      View in: PubMed   Mentions: 1  
    30. Digital directly observed therapy to monitor adherence to medications: a scoping review. HIV Res Clin Pract. 2022 07 18; 23(1):47-60. Stoner MCD, Maragh-Bass AC, Sukhija-Cohen AC, Saberi P. PMID: 35904111; PMCID: PMC9554236.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    31. Understanding HIV Pre-Exposure Prophylaxis Questions of U.S. Health Care Providers: Unique Perspectives from the PrEPline Clinical Teleconsultation Service. Telemed J E Health. 2023 03; 29(3):376-383. Saberi P, Mehtani NJ, Sayegh A, Camp CE, Chu C. PMID: 35802493; PMCID: PMC10024264.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    32. Perceptions of Risks and Benefits of Participating in HIV Cure-Related Research Among Diverse Young Adults Living with HIV in the United States: Qualitative Research Findings. AIDS Res Hum Retroviruses. 2022 08; 38(8):649-659. Saberi P, Campbell CK, Sauceda JA, Ndukwe S, Dubé K. PMID: 35579937; PMCID: PMC9464049.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions. AIDS. 2022 11 01; 36(13):1783-1789. Saberi P, Stoner MCD, Ming K, Lisha NE, Hojilla JC, Scott HM, Liu AY, Steward WT, Johnson MO, Neilands TB. PMID: 35730363; PMCID: PMC9529898.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    34. Lessons Learned from an HIV Pre-Exposure Prophylaxis Coordination Program in San Francisco Primary Care Clinics. AIDS Res Hum Retroviruses. 2022 08; 38(8):611-614. Shrestha I, Ming K, Jimenez V, Wendelborn J, Vazquez A, Steward W, Scott H, Saberi P. PMID: 35592996; PMCID: PMC9419977.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    35. Sexual Behaviors, Substance Use, and Quality of Life Among Individuals Using PrEP in San Francisco During the COVID-19 Pandemic Shelter-In-Place Orders: A Cross-Sectional Survey. J Acquir Immune Defic Syndr. 2022 04 01; 89(4):e39-e42. Chan CT, Ming K, Camp C, Saberi P. PMID: 34974469; PMCID: PMC8881333.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    36. Equity in access to long-acting injectables in the USA. Lancet HIV. 2022 03; 9(3):e145-e147. Hojilla JC, Gandhi M, Satre DD, Johnson MO, Saberi P. PMID: 35131041; PMCID: PMC8936932.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    37. Feasibility and Acceptability of Home-Collected Samples for Human Immunodeficiency Virus Preexposure Prophylaxis and Severe Acute Respiratory Syndrome Coronavirus 2 Laboratory Tests in San Francisco Primary Care Clinics. Open Forum Infect Dis. 2022 Feb; 9(2):ofab657. Saberi P, Ming K, Shrestha I, Scott H, Thorson B, Liu A. PMID: 35087913; PMCID: PMC8789566.
      View in: PubMed   Mentions: 5  
    38. Bringing social context into global biomedical HIV cure-related research: An urgent call to action. J Virus Erad. 2022 Mar; 8(1):100062. Miall A, McLellan R, Dong K, Ndung'u T, Saberi P, Sauceda JA, Dubé K. PMID: 35169489; PMCID: PMC8829132.
      View in: PubMed   Mentions: 11  
    39. We are Family: A Feasibility and Acceptability Study of an HIV Prevention Intervention With the House Ball and Gay Family Communities. J Acquir Immune Defic Syndr. 2021 12 15; 88(S1):S6-S11. Arnold EA, Saberi P, Wong JO, Pollack LM, Neilands TB, Benjamin M, Lockett G, Kegeles SM. PMID: 34757987; PMCID: PMC8579983.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Illustrating HIV Cure Research Strategies for the Next Generation of Research Participants: A Research-Community Collaboration. AIDS Res Hum Retroviruses. 2022 01; 38(1):5-10. Saberi P, Campbell CK, Lee EY, Guzman J, McCormack-Sharp MM, Dubé K. PMID: 34779679; PMCID: PMC8785759.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    41. Antiretroviral therapy experience, satisfaction, and preferences among a diverse sample of young adults living with HIV. AIDS Care. 2022 09; 34(9):1212-1218. Campbell CK, Dubé K, Sauceda JA, Ndukwe S, Saberi P. PMID: 34793253; PMCID: PMC9114167.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Study protocol: a pilot randomised waitlist-controlled trial of a dyadic mobile health intervention for black sexual-minority male couples with HIV in the USA. BMJ Open. 2021 09 02; 11(9):e055448. Kim HC, Pollack LM, Saberi P, Neilands TB, Arnold EA, Bright DJ, Williams RW, Kegeles SM, Tan JY. PMID: 34475191; PMCID: PMC8413948.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    43. A Mobile Health App (WYZ) for Engagement in Care and Antiretroviral Therapy Adherence Among Youth and Young Adults Living With HIV: Single-Arm Pilot Intervention Study. JMIR Form Res. 2021 Aug 31; 5(8):e26861. Saberi P, Lisha NE, Erguera XA, Hudes ES, Johnson MO, Ruel T, Neilands TB. PMID: 34463622; PMCID: PMC8441610.
      View in: PubMed   Mentions: 9  
    44. Ethics of HIV cure research: an unfinished agenda. BMC Med Ethics. 2021 06 30; 22(1):83. Dubé K, Kanazawa J, Taylor J, Dee L, Jones N, Roebuck C, Sylla L, Louella M, Kosmyna J, Kelly D, Clanton O, Palm D, Campbell DM, Onaiwu MG, Patel H, Ndukwe S, Henley L, Johnson MO, Saberi P, Brown B, Sauceda JA, Sugarman J. PMID: 34193141; PMCID: PMC8243312.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    45. Considerations for Increasing Racial, Ethnic, Gender, and Sexual Diversity in HIV Cure-Related Research with Analytical Treatment Interruptions: A Qualitative Inquiry. AIDS Res Hum Retroviruses. 2022 01; 38(1):50-63. Dubé K, Kanazawa J, Campbell C, Boone CA, Maragh-Bass AC, Campbell DM, Agosto-Rosario M, Stockman JK, Diallo DD, Poteat T, Johnson M, Saberi P, Sauceda JA. PMID: 33947268; PMCID: PMC8785755.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    46. Facilitators and barriers of 2-1-1 HIV pre-exposure prophylaxis. PLoS One. 2021; 16(5):e0251917. Camp C, Saberi P. PMID: 34014998; PMCID: PMC8136636.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansPHPublic Health
    47. HIV Preexposure Prophylaxis in the Time of COVID-19: How a Robust and Responsive HIV Preexposure Prophylaxis Intervention Can Avert Loss of HIV Prevention Coverage During a Global Pandemic. J Acquir Immune Defic Syndr. 2021 05 01; 87(1):e173-e176. Saberi P, Ming K, Hojilla JC, Scott HM, Neilands TB. PMID: 33534275; PMCID: PMC8026519.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    48. Development of the Mobile Technology Vulnerability Scale among Youth and Young Adults Living with HIV. Int J Environ Res Public Health. 2021 04 15; 18(8). Lisha NE, Neilands TB, Erguera XA, Saberi P. PMID: 33920803; PMCID: PMC8071158.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    49. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 8; 11(4):e042713. McCuistian MC, Wootton WA, Legnitto-Packard LD, Gruber GV, Dawson-Rose DC, Johnson JM, Saberi SP. .
      View in: Publisher Site   Mentions:
    50. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 08; 11(4):e042713. McCuistian C, Wootton AR, Legnitto-Packard D, Gruber VA, Dawson-Rose C, Johnson MO, Saberi P. PMID: 38058024; PMCID: PMC8039246.
      View in: PubMed   Mentions: 1     Fields:    
    51. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2022 01; 38(1):2-4. Saberi P, Campbell CK, Venegas M, Dubé K. PMID: 33677996; PMCID: PMC8785756.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    52. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pract. 2021 02; 22(1):14-30. Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. PMID: 33757411; PMCID: PMC8272285.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    53. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemed Rep. 2021; 2(1):14-25. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. PMID: 33575683; PMCID: PMC7869821.
      View in: PubMed   Mentions: 9  
    54. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Res Hum Retroviruses. 2021 02; 37(2):75-88. Kanazawa JT, Saberi P, Sauceda JA, Dubé K. PMID: 33176429; PMCID: PMC8020525.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    55. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PLoS One. 2020; 15(10):e0240745. Saberi P, Ming K, Scott H, Liu A, Steward W. PMID: 33064763; PMCID: PMC7567425.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    56. Re-examining the HIV 'functional cure' oxymoron: Time for precise terminology? J Virus Erad. 2020 Nov; 6(4):100017. Dubé K, Willenberg L, Dee L, Sylla L, Taylor J, Roebuck C, Palm D, Campbell D, Newton L, Patel H, Perry KE, Kanazawa J, Gerrard J, Brown B, Saberi P, Sauceda JA, Peluso MJ. PMID: 33251025; PMCID: PMC7646673.
      View in: PubMed   Mentions: 9  
    57. Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 10 13; 222(10):1607-1611. Sauceda JA, Neilands TB, Lightfoot M, Saberi P. PMID: 32860499; PMCID: PMC7499587.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    58. We are family: designing and developing a mobile health application for the San Francisco bay area House Ball and Gay Family communities. Mhealth. 2020; 6:42. Saberi P, Berrean B, Milionis C, Wong JO, Arnold E. PMID: 33437838; PMCID: PMC7793014.
      View in: PubMed   Mentions: 4  
    59. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Res Hum Retroviruses. 2020 12; 36(12):1054-1058. Dubé K, Campbell DM, Perry KE, Kanazawa JT, Saberi P, Sauceda JA, Poteat T, Evans D. PMID: 32829645; PMCID: PMC7703233.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    60. Altruism: Scoping review of the literature and future directions for HIV cure-related research. J Virus Erad. 2020 Nov; 6(4):100008. Dubé K, Perry KE, Mathur K, Lo M, Javadi SS, Patel H, Concha-Garcia S, Taylor J, Kaytes A, Dee L, Campbell D, Kanazawa J, Smith D, Gianella S, Auerbach JD, Saberi P, Sauceda JA. PMID: 33294210; PMCID: PMC7695811.
      View in: PubMed   Mentions: 14  
    61. Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic. AIDS Behav. 2020 08; 24(8):2232-2235. Saberi P. PMID: 32303924; PMCID: PMC7165077.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCellsPHPublic Health
    62. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020 07 14; 10(7):e040734. Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. PMID: 32665393; PMCID: PMC7454188.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansPHPublic Health
    63. Attitudes about community pharmacy access to HIV prevention medications in California. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):e179-e183. Koester KA, Saberi P, Fuller SM, Arnold EA, Steward WT. PMID: 32665097; PMCID: PMC7875193.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansPHPublic Health
    64. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS Res Hum Retroviruses. 2020 07; 36(7):606-615. Saberi P, Eskaf S, Sauceda J, Evans D, Dubé K. PMID: 32368934; PMCID: PMC7398435.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    65. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know. J Gen Intern Med. 2020 04; 35(4):1285-1288. Saberi P, Scott HM. PMID: 31965523; PMCID: PMC7174437.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansPHPublic Health
    66. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS Behav. 2020 Jan; 24(1):284-290. Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB. PMID: 31758349; PMCID: PMC6996539.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    67. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 04; 36(4):324-348. Dubé K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. PMID: 31608651; PMCID: PMC7185332.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    68. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2020 10; 26(10):1278-1283. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. PMID: 31800368; PMCID: PMC11708184.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    69. Telehealth and texting intervention to improve HIV care engagement, mental health and substance use outcomes in youth living with HIV: a pilot feasibility and acceptability study protocol. BMJ Open. 2019 07 16; 9(7):e028522. Wootton AR, Legnitto DA, Gruber VA, Dawson-Rose C, Neilands TB, Johnson MO, Saberi P. PMID: 31315868; PMCID: PMC6661640.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    70. Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area. J Adolesc Health. 2019 08; 65(2):262-266. Reeder C, Neilands TB, Palar K, Saberi P. PMID: 31196781; PMCID: PMC7123582.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    71. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020 08; 32(8):931-939. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. PMID: 31132864; PMCID: PMC6881543.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    72. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV. BMJ Open. 2019 05 05; 9(5):e030473. Erguera XA, Johnson MO, Neilands TB, Ruel T, Berrean B, Thomas S, Saberi P. PMID: 31061063; PMCID: PMC6501960.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    73. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study. PLoS One. 2019; 14(1):e0210791. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. PMID: 30645641; PMCID: PMC6333375.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    74. The Association between Use of Online Social Networks to Find Sex Partners and Sexually Transmitted Infection Diagnosis among Young Men Who Have Sex with Men and Transgender Women Living with HIV. J Int Assoc Provid AIDS Care. 2019 Jan-Dec; 18:2325958219867324. Saberi P, Neilands TB, Lally MA, Hosek SG, Hightow-Weidman L. PMID: 31389285; PMCID: PMC6900576.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    75. Role of a clinical pharmacist as part of a multidisciplinary care team in the treatment of HCV in patients living with HIV/HCV coinfection. Integr Pharm Res Pract. 2018; 7:105-111. Olea A, Grochowski J, Luetkemeyer AF, Robb V, Saberi P. PMID: 30214893; PMCID: PMC6118274.
      View in: PubMed   Mentions: 11  
    76. Novel methods to estimate antiretroviral adherence: protocol for a longitudinal study. Patient Prefer Adherence. 2018; 12:1033-1042. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. PMID: 29950816; PMCID: PMC6014386.
      View in: PubMed   Mentions: 10  
    77. What does it mean to be youth-friendly? Results from qualitative interviews with health care providers and clinic staff serving youth and young adults living with HIV. Adolesc Health Med Ther. 2018; 9:65-75. Saberi P, Ming K, Dawson-Rose C. PMID: 29731672; PMCID: PMC5927154.
      View in: PubMed   Mentions: 13  
    78. An update on the Barriers to Adherence and a Definition of Self-Report Non-adherence Given Advancements in Antiretroviral Therapy (ART). AIDS Behav. 2018 03; 22(3):939-947. Sauceda JA, Neilands TB, Johnson MO, Saberi P. PMID: 28352983; PMCID: PMC5617751.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    79. A Simple Pre-Exposure Prophylaxis (PrEP) Optimization Intervention for Health Care Providers Prescribing PrEP: Pilot Study. JMIR Form Res. 2018 Jan-Jun; 2(1). Saberi P, Berrean B, Thomas S, Gandhi M, Scott H. PMID: 30637375; PMCID: PMC6325636.
      View in: PubMed   Mentions: 16  
    80. Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States. Clin Infect Dis. 2018 01 06; 66(2):213-219. Koss CA, Hosek SG, Bacchetti P, Anderson PL, Liu AY, Horng H, Benet LZ, Kuncze K, Louie A, Saberi P, Wilson CM, Gandhi M. PMID: 29020194; PMCID: PMC5850042.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansPHPublic Health
    81. Strong Correlation Between Concentrations of Antiretrovirals in Home-Collected and Study-Collected Hair Samples: Implications for Adherence Monitoring. J Acquir Immune Defic Syndr. 2017 12 01; 76(4):e101-e103. Saberi P, Neilands TB, Ming K, Johnson MO, Kuncze K, Koss CA, Gandhi M. PMID: 28657913; PMCID: PMC5659889.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    82. Chapter 5: HIV Treatment Failure and Resistance. HIV Pharmacotherapy: The Pharmacist’s Role in Care and Treatment. 2017 Nov 1; 85-101. Grochowski GJ, Saberi SP. .
      View in: Publisher Site   Mentions:
    83. Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era? AIDS Behav. 2016 11; 20(11):2624-2628. Sauceda JA, Johnson MO, Saberi P. PMID: 26767532; PMCID: PMC4945486.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    84. Using Path Analysis to Evaluate the Healthcare Empowerment Model Among Persons Living with HIV for Antiretroviral Therapy Adherence. AIDS Patient Care STDS. 2016 11; 30(11):497-505. van den Berg JJ, Neilands TB, Johnson MO, Chen B, Saberi P. PMID: 27849372; PMCID: PMC5116681.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    85. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 06; 30(6):254-60. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. PMID: 27214751; PMCID: PMC4913493.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    86. Evaluation of short message service and peer navigation to improve engagement in HIV care in South Africa: study protocol for a three-arm cluster randomized controlled trial. Trials. 2016 Feb 06; 17:68. Lippman SA, Shade SB, Sumitani J, DeKadt J, Gilvydis JM, Ratlhagana MJ, Grignon J, Tumbo J, Gilmore H, Agnew E, Saberi P, Barnhart S, Steward WT. PMID: 26852237; PMCID: PMC4744624.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    87. Need for improvements in clinical practice to retain patients in pre-antiretroviral therapy care: Data from rural clinics in North West Province, South Africa. AIDS Care. 2015; 27(10):1275-8. Gilvydis JM, Steward WT, Saberi P, Tumbo J, Sumitani J, Barnhart S, Lippman SA. PMID: 26278130; PMCID: PMC4780844.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    88. Correlation of Internet Use for Health Care Engagement Purposes and HIV Clinical Outcomes Among HIV-Positive Individuals Using Online Social Media. J Health Commun. 2015; 20(9):1026-32. Saberi P, Johnson MO. PMID: 26120890; PMCID: PMC4699567.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    89. Antiretroviral Therapy Adherence and Use of an Electronic Shared Medical Record Among People Living with HIV. AIDS Behav. 2015 Jun; 19 Suppl 2:177-85. Saberi P, Catz SL, Leyden WA, Stewart C, Ralston JD, Horberg MA, Grothaus L, Silverberg MJ. PMID: 25572829; PMCID: PMC4497945.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    90. Barriers to antiretroviral therapy adherence and plasma HIV RNA suppression among AIDS clinical trials group study participants. AIDS Patient Care STDS. 2015 Mar; 29(3):111-6. Saberi P, Neilands TB, Vittinghoff E, Johnson MO, Chesney M, Cohn SE. PMID: 25615029; PMCID: PMC4352694.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    91. Correlation between use of antiretroviral adherence devices by HIV-infected youth and plasma HIV RNA and self-reported adherence. AIDS Behav. 2015 Jan; 19(1):93-103. Saberi P, Mayer K, Vittinghoff E, Naar-King S, Adolescent Medicine Trials Network for HIV/AIDS Interventions. PMID: 24879628; PMCID: PMC4250439.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    92. Moving toward a novel and comprehensive behavioral composite of engagement in HIV care. AIDS Care. 2015; 27(5):660-4. Saberi P, Johnson MO. PMID: 25471139; PMCID: PMC4336586.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    93. Association between Dog Guardianship and HIV Clinical Outcomes. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2014 Jul 1; 13(4):300-304. Saberi SP, Neilands NT, Johnson JM. .
      View in: Publisher Site   Mentions:
    94. Using online social media for recruitment of human immunodeficiency virus-positive participants: a cross-sectional survey. J Med Internet Res. 2014 May 01; 16(5):e117. Yuan P, Bare MG, Johnson MO, Saberi P. PMID: 24784982; PMCID: PMC4026571.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    95. Correlates of antiretroviral adherence and viral load among transgender women living with HIV. AIDS Care. 2014; 26(8):976-82. Sevelius JM, Saberi P, Johnson MO. PMID: 24646419; PMCID: PMC4054817.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    96. Reporting of critical information in studies of pharmacists in HIV care. Int J Pharm Pract. 2014 Dec; 22(6):375-85. Cocohoba J, Dong BJ, Johnson MO, Saberi P. PMID: 24467531; PMCID: PMC4112174.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    97. A pilot study to engage and counsel HIV-positive African American youth via telehealth technology. AIDS Patient Care STDS. 2013 Sep; 27(9):529-32. Saberi P, Yuan P, John M, Sheon N, Johnson MO. PMID: 23991691; PMCID: PMC3760070.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    98. Qualitative study of the quality of sleep in marginalized individuals living with HIV. Patient Prefer Adherence. 2013; 7:499-507. Saberi P, Comfort M, Sheon N, Johnson MO. PMID: 23807839; PMCID: PMC3687846.
      View in: PubMed   Mentions: 6  
    99. Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management. HIV Med. 2013 Oct; 14(9):519-29. Saberi P, Phengrasamy T, Nguyen DP. PMID: 23590676; PMCID: PMC3758391.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    100. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012; 7(11):e50061. Saberi P, Gamarel KE, Neilands TB, Comfort M, Sheon N, Darbes LA, Johnson MO. PMID: 23166819; PMCID: PMC3498189.
      View in: PubMed   Mentions: 59     Fields:    Translation:HumansCellsPHPublic Health
    101. Pharmacists as providers of HIV pre-exposure prophylaxis. Int J Clin Pharm. 2012 Dec; 34(6):803-6. Bruno C, Saberi P. PMID: 23073703; PMCID: PMC3501608.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    102. Directly observed versus self-administered antiretroviral therapies: preference of HIV-positive jailed inmates in San Francisco. J Urban Health. 2012 Oct; 89(5):794-801. Saberi P, Caswell NH, Jamison R, Estes M, Tulsky JP. PMID: 22547327; PMCID: PMC3462822.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    103. The relationship between daily organization and adherence to antiretroviral therapy: a qualitative perspective. J Acquir Immune Defic Syndr. 2012 Sep 01; 61(1):e3-6. Saberi P, Comfort M, Johnson MO. PMID: 22918127; PMCID: PMC3427530.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    104. Preliminary support for the construct of health care empowerment in the context of treatment for human immunodeficiency virus. Patient Prefer Adherence. 2012; 6:395-404. Johnson MO, Sevelius JM, Dilworth SE, Saberi P, Neilands TB. PMID: 22654510; PMCID: PMC3363300.
      View in: PubMed   Mentions: 22  
    105. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:297-322. Saberi P, Dong BJ, Johnson MO, Greenblatt RM, Cocohoba JM. PMID: 22536064; PMCID: PMC3333818.
      View in: PubMed   Mentions: 36  
    106. Technology-based self-care methods of improving antiretroviral adherence: a systematic review. PLoS One. 2011; 6(11):e27533. Saberi P, Johnson MO. PMID: 22140446; PMCID: PMC3227571.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    107. Medication adherence: tailoring the analysis to the data. AIDS Behav. 2011 Oct; 15(7):1447-53. Saberi P, Johnson MO, McCulloch CE, Vittinghoff E, Neilands TB. PMID: 21833689; PMCID: PMC3216469.
      View in: PubMed   Mentions: 12     Fields:    
    108. Quality of sleep: associations with antiretroviral nonadherence. AIDS Patient Care STDS. 2011 Sep; 25(9):517-24. Saberi P, Neilands TB, Johnson MO. PMID: 21770763; PMCID: PMC3157301.
      View in: PubMed   Mentions: 21     Fields:    
    109. An Increase in Serum Creatinine after Initiation of Fenofibrate in an HIV-Infected Individual: A Case Report and Review of the Literature. J Int Assoc Physicians AIDS Care (Chic). 2011 Jul-Aug; 10(4):219-22. Bruno CB, Schapiro JM, Saberi P. PMID: 21518854; PMCID: PMC3222949.
      View in: PubMed   Mentions: 1     Fields:    
    110. Clinical implications of the nelfinavir-proton pump inhibitor drug interaction in patients with human immunodeficiency virus. Pharmacotherapy. 2011 Mar; 31(3):253-61. Saberi P, Ranatunga DK, Quesenberry CP, Silverberg MJ. PMID: 21361735; PMCID: PMC3091502.
      View in: PubMed   Mentions: 2     Fields:    
    111. Improving adherence and clinical outcomes through an HIV pharmacist's interventions. AIDS Care. 2010 Oct; 22(10):1189-94. Ma A, Chen DM, Chau FM, Saberi P. PMID: 20640958.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    112. Pharmacy-refill measure of adherence to efavirenz can predict maintenance of HIV viral suppression. AIDS Care. 2008 Jul; 20(6):741-5. Saberi P, Caswell N, Amodio-Groton M, Alpert P. PMID: 18576177.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    113. Immunologic benefits of enfuvirtide in patients enrolled in a drug assistance program. Ann Pharmacother. 2008 May; 42(5):621-6. Saberi P, Caswell NH, Gruta CI, Tokumoto JN, Dong BJ. PMID: 18413688.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    114. A Rainforest Expedition with The Student Rainforest Fund. Journal of Herbal Pharmacotherapy. 2005 Jan 1; 5(3):103-105. Riedlinger RJ, Higgins HN, Saberi SP. .
      View in: Publisher Site   Mentions:
    Parya's Networks
    Concepts (233)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (70)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.